Special Topic: The Warburg Effect: Its Continued Impact on Cancer Research into the 21st Century
211-222
Introduction
Warburg, me and Hexokinase 2: Multiple discoveries of key molecular events underlying one of cancers’ most common phenotypes, the “Warburg Effect”, i.e., elevated glycolysis in the presence of oxygen
Peter L. Pedersen
223-229
Mini Review
Hypoxia, glucose metabolism and the Warburg’s effect
Ramon Bartrons and Jaime Caro
231-234
Mini Review
HIF-1 mediates the Warburg effect in clear cell renal carcinoma
Gregg L. Semenza
235-241
Mini Review
Actuality of Warburg’s views in our understanding of renal cancer metabolism
Catherine Godinot, Elodie de Laplanche, Eric Hervouet and Hélène Simonnet
243-246
Mini Review
A pivotal role for p53: balancing aerobic respiration and glycolysis
Wenzhe Ma, Ho Joong Sung, Joon Y. Park, Satoaki Matoba and Paul M. Hwang
247-250
Mini Review
Oxygen metabolism and a potential role for cytochrome c oxidase in the Warburg effect
Paul C. Herrmann and E. Clifford Herrmann
251-257
Mini Review
Adaptive landscapes and emergent phenotypes: why do cancers have high glycolysis?
Robert J. Gillies and Robert A. Gatenby
259-265
Mini Review
A message emerging from development: the repression of mitochondrial β-F1-ATPase expression in cancer
José M. Cuezva, María Sánchez-Aragó, Sandra Sala, Amaya Blanco-Rivero and Álvaro D. Ortega
267-274
MIni Review
The Warburg effect and its cancer therapeutic implications
Zhao Chen, Weiqin Lu, Celia Garcia-Prieto and Peng Huang